Health
From Guangzhou to the World: Onuge Group showcase of Innovation and Quality at Cosmoprof Bologna 2024
GUANGDONG, China, March 23, 2024 /PRNewswire/ -- The Cosmoprof Bologna, a premier B2B beauty event with a legacy spanning over half a century, Founded in 1967. Once again hosted the Cosmoprof of the global beauty industry fromMarch 21st to 24th, 2024. Organized by the Bologna Exhibition Group, th...
2024-03-23 16:11
2452
Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
HANGZHOU, China, March 22, 2024 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market inChina, announced its annual financial results for 2023. The report underlines a year of remarkable ...
2024-03-22 17:14
2460
100% CBR! FDA Granted ODD to Biostar Pharma's Utidelone Capsule (UTD2) for the Treatment of Gastric Cancer
SAN FRANCISCO, March 21, 2024 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic biology driven biopharma company focusing on the development and commercialization of innovative oncology drugs, announced today that their ...
2024-03-21 20:30
1291
FDA Grants Orphan Drug Designation to Cevidoplenib for ITP
PANGYO, South Korea, March 21, 2024 /PRNewswire/ -- Oscotec Inc. has secured orphan drug designation (ODD) from the U.S. Food and Drug Administration (FDA) for its SYK inhibitor, Cevidoplenib, to treat immune thrombocytopenia (ITP). Oscotec has successfully completed phase 2 study in patients wit...
2024-03-21 20:00
1410
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update
* Full-year 2023 net revenue reaches 135 billion KRW, driven by strong sales growth. * R&D momentum persisted with promising developments in anti-FcRn antibodies HL161ANS and batoclimab, positioning them as potentially best-in-class treatments for lgG-mediated autoimmune diseases. * Anticip...
2024-03-21 19:00
1402
Biosion to Present Three Posters at the 2024 AACR Meeting
NEWARK, Del. and NANJING, China, March 21, 2024 /PRNewswire/ -- Biosion, a global, clinical-stage biotechnology company, today announced upcoming presentations of pre-clinical data for its oncology pipeline assets, including BSI-111, an anti-CD16a monoclonal antibody, BSI-730, a HER2/PD-L1 bispec...
2024-03-21 19:00
1269
111, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
SHANGHAI, March 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the fourth qua...
2024-03-21 16:47
2541
Mabwell Presented IDDC™ Platform Technology and ADC Drug Development Achievements at the 14th World ADC London
SHANGHAI, March 21, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, published "Mtoxin™ Payload Applied in IDDC™ ADC Platform Significant Increases Therapeutic Index and Overcome MultiDrug Resistance in Various Tumor" as poster ...
2024-03-21 14:11
1340
Ubie Launches Checkup Platform for Patient Self-Monitoring, Medication Management and Improved Provider Communication
* Patient health management can be difficult due to limited time with doctors during appointments, low health literacy and poor recall of doctor recommendations * Routine patient generated data can ensure patients stay on track, provide a comprehensive view of health, and provide critical inf...
2024-03-20 22:00
1244
Origin Agritech Announces Breakthrough in High-Yield Corn Production Through Gene Editing
Inbred Line Yield Increased Over 50% in Trials BEIJING, March 20, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced a major breakthrough in corn production technology. Building on the Company's...
2024-03-20 20:00
1342
So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results
BEIJING, March 20, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial resu...
2024-03-20 17:30
1976
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement
HANGZHOU, China, March 19, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...
2024-03-20 04:05
1850
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential
SHANGHAI, March 19, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative-driven biopharmaceutical company with entire industry chain, presented the clinical study data of the 9MW2821 for patients with cervical cancer as focused plenary oral presentation at the Society of Gynecologic Oncology ...
2024-03-19 22:00
1379
Datasea Enters into Manufacturing Agreement to Accelerate Production and Deployment of its Hi-Tech Intelligent Acoustic Products
BEIJING, March 19, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a digital technology company incorporated inNevada, dedicated to innovative business in acoustic high tech and 5G-Artificial Intelligence multimodal communication technology inthe United States and C...
2024-03-19 22:00
1272
Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study
* The world's first non-surgical cervical HSIL treatment validated by an international Phase III clinical study with proven efficacy; * The response rate increased by 89.4% compared to the placebo control group, with a low incidence of adverse events; * The China new drug application submiss...
2024-03-19 10:24
1168
Waterdrop Launches Groundbreaking X Series Reverse Osmosis System, Redefining Standards for Clean, Healthy, and Sustainable Drinking Water
LOS ANGELES, March 18, 2024 /PRNewswire/ -- Waterdrop, an industry leader in water filtration, is thrilled to announce the launch of its most advanced water filtration system - the Waterdrop X Series Reverse Osmosis System. This state-of-the-art product revolutionizes water purification with c...
2024-03-19 10:07
1404
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC
SHANGHAI, March 18, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry is a digital biology pioneer company that specializes in AI-driven protein design and R&D platform. Sanyou Bio is a world-leading high-tec...
2024-03-19 08:00
1071
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal
* New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League Against Cancer SEOUL, South Korea, March 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diag...
2024-03-18 21:00
1580
WuXi AppTec Revenue Surpassed RMB40 Billion in 2023, and Adjusted Non-IFRS Net Profit Exceeded RMB10 Billion for the First Time
* Revenue Up 2.5% Year-over-Year to RMB40,341 Million; Excluding COVID-19 Commercial Projects, Up 25.6% * Net Profit Attributable to the Owners of the Company[1] Increased 9.0% to RMB9,607 Million; Diluted Earnings per Share (EPS) Increased 14.9% to RMB3.24 * Adjusted Non-IFRS Net Profit Att...
2024-03-18 20:32
2221
Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System
SUNNYVALE, Calif., March 18, 2024 /PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone with initiation of its investigational device exemption (IDE) clinical tri...
2024-03-18 20:00
1048
Week's Top Stories
Most Reposted
Labuan IBFC Inc. and STEP Malaysia jointly host wealth management and estate planning event
[Picked up by 318 media titles]
2024-06-28 12:45
Co-creating a Digital and Intelligent World, H3C Digital Tour 2024 Concludes Successfully
[Picked up by 291 media titles]
2024-07-04 12:02
Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA
[Picked up by 291 media titles]
2024-07-01 09:05
Hukumonline Launches Comprehensive Law Firm Directory As a Guide for Investment and Business in Indonesia
[Picked up by 285 media titles]
2024-06-28 21:46
AI and Sustainability in Advanced Manufacturing to take Centre Stage at Industrial Transformation ASIA-PACIFIC (ITAP) 2024
[Picked up by 281 media titles]
2024-07-03 15:51
Most Read
Labuan IBFC Inc. and STEP Malaysia jointly host wealth management and estate planning event
2024-06-28 12:45
13157
iQIYI Unveils Over 250 New Shows at 4th Annual Content Showcase in North America
2024-06-28 19:00
11004
Hukumonline Launches Comprehensive Law Firm Directory As a Guide for Investment and Business in Indonesia
2024-06-28 21:46
10976
Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA
2024-07-01 09:05
10458
Enchanting Deyang Shines in Hong Kong
2024-06-29 17:48
9089
